Pain catastrophizing is associated with the Val66Met polymorphism of the brain-derived neurotrophic factor in fibromyalgia

被引:16
|
作者
da Silveira Alves, Camila Fernanda [1 ,2 ,3 ,4 ]
Caumo, Wolnei [3 ,4 ,5 ]
Silvestri, Joana Morez [2 ]
Zortea, Maxciel [3 ,4 ]
dos Santos, Vinicius Souza [3 ,4 ]
Cardoso, Dayane Favarin [2 ]
Regner, Andrea [1 ]
de Souza, Alessandra Hubner [1 ]
Simon, Daniel [1 ,2 ]
机构
[1] Univ Luterana Brasil ULBRA, Grad Program Cellular & Mol Biol Appl Hlth, Av Farroupilha,8001 Predio 22,5 Andar, BR-92425900 Canoas, RS, Brazil
[2] Univ Luterana Brasil ULBRA, Human Mol Genet Lab, Canoas, Brazil
[3] Hosp Clin Porto Alegre HCPA, Lab Pain & Neuromodulat, Porto Alegre, RS, Brazil
[4] Univ Fed Rio Grande do Sul UFRGS, Grad Program Med Sci, Porto Alegre, RS, Brazil
[5] Univ Fed Rio Grande do Sul UFRGS, Hosp Clin Porto Alegre HCPA, Sch Med, Pain & Palliat Care Serv,Dept Surg, Porto Alegre, RS, Brazil
关键词
Fibromyalgia; Pain catastrophizing; BDNF; Single nucleotide polymorphism; Val66Met; BRAZILIAN PORTUGUESE VERSION; BIPOLAR DISORDER; HUMAN-MEMORY; LIFE STRESS; FACTOR GENE; BDNF; SENSITIZATION; DEPRESSION; RESPONSES; RISK;
D O I
10.1186/s42358-020-00141-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Fibromyalgia (FM) is a musculoskeletal chronic pain syndrome that impacts negatively patient's daily lives. Its pathogenesis is characterized by a complex relationship between biological and psychosocial factors not fully understood yet. Pain catastrophizing is associated with FM and is an important predictor of outcomes. This study aimed to answer two questions: (i) whether the allele and genotype frequencies of BDNF Val66Met (rs6265) polymorphism differs between FM patients and healthy controls (HC); and (ii) if the BDNF Val66Met polymorphism is a factor that predicts pain catastrophizing in FM. Methods In a cross-sectional design, 108 FM patients and 108 HC were included. FM patients responded to the Brazilian Portuguese version of the Pain Catastrophizing Scale (BP-PCS) to assess pain catastrophizing, as well as other validated tools for anxiety (The State-Trait Anxiety Inventory - STAI), depression (Beck Depression Inventory II-BDI-II) and functional aspects (Fibromyalgia Impact Questionnaire - FIQ; Central Sensitization Inventory validated and adapted for Brazilian population - CSI-BP; Pittsburgh Sleep Quality Index - PSQI; and Resilience Scale). All subjects were genotyped for the BDNF Val66Met polymorphism. Results Val allele was significantly more frequent in FM patients compared to the control group (p < 0.05). Also, FM patients with Val/Val genotype showed more pain catastrophizing thoughts, and this genotype was significantly associated with magnification and rumination dimensions of BP-PCS (p < 0.05). Furthermore, there were significant differences in levels of anxiety and symptoms of depression, years of education, and the functional situation between the FM and control groups. Conclusions The findings show an association of BDNF Val66Met polymorphism with pain catastrophizing in FM, which opens new avenues to comprehend the interplay between molecular genetic characteristics and neuroplasticity mechanisms underpinning FM.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] An associatiton mudy of the brain-derived neurotrophic factor val66met polymorphism and amphetamine response
    Flanagin, Brody A.
    Cook, Edwin H., Jr.
    de Wit, Harriet
    AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2006, 141B (06) : 576 - 583
  • [22] Brain-Derived Neurotrophic Factor Val66Met Polymorphism: Association With Psychopathological Symptoms of Schizophrenia?
    Chang, Hsin-An
    Lu, Ru-Band
    Shy, Mee-Jen
    Chang, Chuan-Chia
    Lee, Meei-Shyuan
    Huang, San-Yuan
    JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 2009, 21 (01) : 30 - 37
  • [23] Brain-derived neurotrophic factor polymorphism Val66Met influences cognitive abilities in the elderly
    Miyajima, F.
    Ollier, W.
    Mayes, A.
    Jackson, A.
    Thacker, N.
    Rabbitt, P.
    Pendleton, N.
    Horan, M.
    Payton, A.
    GENES BRAIN AND BEHAVIOR, 2008, 7 (04) : 411 - 417
  • [24] BRAIN-DERIVED NEUROTROPHIC FACTOR GENE POLYMORPHISM (VAL66MET) AND THE RESPONSE TO ESCITALOPRAM IN DEPRESSION
    El-Hage, W.
    EUROPEAN PSYCHIATRY, 2013, 28
  • [25] Brain-derived neurotrophic factor (Val66Met) polymorphism and olfactory ability in young adults
    Alessandro Tonacci
    Andrea Borghini
    Antonella Mercuri
    Giovanni Pioggia
    Maria Grazia Andreassi
    Journal of Biomedical Science, 20
  • [26] The association between brain-derived neurotrophic factor polymorphism (BDNF Val66Met) and suicide
    Pregelj, Peter
    Nedic, Gordana
    Paska, Alja Videtic
    Zupanc, Tomaz
    Nikolac, Matea
    Balazic, Joze
    Tomori, Martina
    Komel, Radovan
    Seler, Dorotea Muck
    Pivac, Nela
    JOURNAL OF AFFECTIVE DISORDERS, 2011, 128 (03) : 287 - 290
  • [27] Val66met polymorphism and serum brain-derived neurotrophic factor levels in bipolar disorder
    Tramontina, J.
    Frey, B. N.
    Andreazza, A. C.
    Zandona, M.
    Santin, A.
    Kapczinski, F.
    MOLECULAR PSYCHIATRY, 2007, 12 (03) : 230 - 231
  • [28] Brain-derived neurotrophic factor Val66Met polymorphism, human memory, and synaptic neuroplasticity
    Lamb, Yvette N.
    McKay, Nicole S.
    Thompson, Christopher S.
    Hamm, Jeffrey P.
    Waldie, Karen E.
    Kirk, Ian J.
    WILEY INTERDISCIPLINARY REVIEWS-COGNITIVE SCIENCE, 2015, 6 (02) : 97 - 108
  • [29] Brain-derived neurotrophic factor gene (BDNF) Val66Met polymorphism in primary dystonia
    Caceres, M. T.
    Gomez-Garre, P.
    Carrillo, F.
    Bernal-Bernal, I.
    Carballo, M.
    Mir, P.
    MOVEMENT DISORDERS, 2011, 26 : S313 - S313
  • [30] No association of the Val66Met polymorphism of brain-derived neurotrophic factor (BDNF) to multiple sclerosis
    Blanco, Y
    Gómez-Choco, M
    Arostegui, JL
    Casanova, B
    Martínez-Rodríguez, JE
    Boscá, I
    Munteis, E
    Yagüe, J
    Graus, F
    Saiz, A
    NEUROSCIENCE LETTERS, 2006, 396 (03) : 217 - 219